Dose modification in enzalutamide and abiraterone plus prednisolone for castration-resistant prostate cancer: A subanalysis from the ENABLE study for PCa.
Tanaka N, Izumi K, Nakai Y, Shima T, Kato Y, Mita K, Kamiyama M, Inoue S, Hoshi S, Okamura T, Yoshio Y, Enokida H, Chikazawa I, Kawai N, Hashimoto K, Fukagai T, Shigehara K, Takahara S, Mizokami A.
Tanaka N, et al. Among authors: shigehara k.
Prostate. 2024 Sep 20. doi: 10.1002/pros.24796. Online ahead of print.
Prostate. 2024.
PMID: 39301921